相关实验视频

Updated: Sep 15, 2025

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

解码TAGLN2在癌症中:分子关键链桥梁阿克丁重塑,免疫失调和治疗挑战

Xie-Lin Yan¹, Jun-Jie Wu², Hui-Bo Ti¹

¹Wuxi Medical College, Jiangnan University, Wuxi, China; Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Jiangsu, China.

International journal of biological macromolecules

|July 17, 2025

概括

转素2 (TAGLN2) 对于癌症的进展至关重要,影响侵袭和免疫规避. 了解它的特定作用和向它可能为各种癌症提供新的精确疗法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

癌症的进展依赖于瘤和微环境的相互作用,而活性细胞骨的动态对于入侵,转移和免疫逃避至关重要.
转基因2 (TAGLN2) 是一个关键的细胞骨调节器,通过actin动力学,信号传导和表观遗传学影响瘤进展.
TAGLN2作为泛癌生物标志物和治疗点具有前景,但其组织特异性表达和机制需要进一步澄清.

研究的目的:

为了阐明TAGLN2的分子和生化特征.
在各种瘤中系统地总结TAGLN2表达特征,并评估相关的信号通路.
检查TAGLN2在瘤发生和进展中的机制,并讨论治疗策略.

主要方法:

文献审查和对TAGLN2.2现有数据的分析.
在不同类型的癌症中对TAGLN2表达模式的系统评估.
对与TAGLN2相关的信号通路和表观遗传修饰的分析2.
对针对TAGLN的当前和潜在治疗策略的审查2.

主要成果:

TAGLN2集成了actin动态,信号和表观遗传修饰,以影响瘤进展.
TAGLN2在临床瘤中表现出多样化的表达模式,影响入侵,转移和免疫逃避.
确定了TAGLN2在瘤发生过程中调节的特定分子机制和信号通路.

结论:

TAGLN2是癌症发展的重要因素,影响了诸如入侵和免疫逃避等关键过程.
进一步研究TAGLN2在瘤微环境中的作用对于开发有效疗法至关重要.
针对TAGLN2,特别是与细胞骨重塑和免疫代谢调节相结合,有望克服瘤异质性和治疗耐药性.

关键词:

动氨酸细胞骨动氨酸细胞骨免疫代谢调节免疫代谢调节治疗耐药性是一种治疗性耐药性.转凝素2 (TAGLN2) 是一种瘤微环境 (TME) 是指瘤的微环境.

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8⁺ T Cells During LN Metastasis

Published on: January 26, 2024

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...